New bacteria in the nostrils will lead humanity through the era of antibiotic resistance

As we know, the era of human antibiotic resistance has arrived, when at the end of May 2016, the bacteria resistant to all current drugs appeared. Accompanied by a lot of resistant "viruses" most antibiotics also flared up.

However, the dark prospect seems to be brightening, as scientists find a weapon that can fight these viruses. And that weapon is a kind of bacteria that is crawling in our nostrils.

More specifically, experts at the University of Tübingen (Germany) conducted research on 90 candidates, and they discovered a strain of bacteria called Staphylococcus lugdunensis.

New strain of Staphylococcus lugdunensis.

Based on that, the team has successfully developed a new antibiotic called Lugdunin , with the ability to resist the common MRSA - methicillin-resistant yellow bacterium in mice, which can cause wound infection in humans.

According to Andreas Peschel, a researcher of the project: "Normally, antibiotics are produced by pathogenic bacteria and fungi. But this study also shows that based on unrelated micro-organisms, we also develop. get antibiotics ".

Furthermore, statistics show that MRSA and new bacteria Staphylococcus lugdunensis rarely appear in the nose. This further demonstrates that the idea of ​​developing antibiotics through microbiology is quite potential.

In addition, one extremely impressive thing is that since 1980, humans have not yet developed a completely new antibiotic strain like this. And according to Peschel: "Lugdunin is just a pioneering drug, the floating part of the iceberg."

This means that there are many other bacteria that can be defeated by Lugdunin, or by some other drugs based on the mysterious bacteria in our nostrils. This will take a few more years to verify.

MRSA and new bacteria Staphylococcus lugdunensis rarely appear in the nose.

However, the battle is not over. Experts say that MRSA can completely resist Lugdunin , so we need to continue to study the next series of antibiotics, but not "sit and play" . Because if MRSA is too strong, it is estimated that by 2050, hundreds of millions of people will die for it.

The study is published in Nature.